SARS-CoV-2 (COVID - 19) IgM/IgG

SARS-CoV-2 (COVID-19) IgM/IgG Ab Rapid Test


- Specimen: Whole Blood/Serum/Plasma

- Fast Reaction: 15 minutes

- IgM Sensitivity: 82%

- IgM Specificity: 97%

- IgG Sensitivity: 93%

- IgG Specificity: 97.5%

  • Introduction
  • Manual
  • Intrusctions

The SARS-CoV-2 IgM/IgG Ab Rapid Test is used to detect the IgM and IgG antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human serum, plasma or whole blood sample qualitatively. It it to be used as an aid in the diagnosis of coronavirus infection disease (COVID-19), which is caused by SARS-CoV-2.

The test provides preliminary test results. Negative results don't preclude SARS-CoV-2 infection and they cannot be used as the sole basis for treatment or other management decision.

COVID-19, it is a novel coronavirus with new strain thathas not been previously identified in humans, belongs to Coronaviruses (CoV) suchas Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome(SARS-CoV).

Product NameSpecimenFormatKit size

SARS-CoV-2 IgM/IgG Ab 

Rapid Test

WB/S/PCassette40T/box, 48 boxes/ctn

Please contact us for any enquiries.


Copyright © HIGHTOP Biotech